David C. Klonoff, M.D. is an endocrinologist specialising in the development and use of diabetes technology. He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at University of California at San Francisco.

His research interests include glucose monitoring, insulin delivery, digital health, cybersecurity, and diabetes data science. He has published more than 350 articles, he is the senior editor of three books about diabetes digital health, and he founded both PubMed-indexed journals about diabetes technology. He is currently editor-in chief of Journal of Diabetes Science and Technology and Medical Director of the Diabetes Research Hub.

Dr. Klonoff received the American Diabetes Association’s 2019 Outstanding Physician Clinician Award. He received an FDA Director’s Special Citation Award in 2010 for outstanding contributions related to diabetes technology. He received the IEEE Standards Association Conformity Assessment Award in 2022. In 2012, Dr. Klonoff was elected as a Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and cited as among the top 2% of the world’s bioengineers for his engineering work in diabetes technology. He received the 2012 Gold Medal Oration and Distinguished Scientist Award from the Dr. Mohan’s Diabetes Specialities Centre and Madras Diabetes Research Foundation of Chennai, India. Dr. Klonoff was invited to speak to the US Congressional Diabetes Caucus in 2017, to participate in the White House Health and Cybersecurity Roundtable in 2015, and to speak at the European Parliament in 2010.

Duality of Interest:

Receipt of honoraria/consultation fees from: Consultant to Afon, embecta, Glucotrack, Lifecare, Novo Nordisk, Samsung, SynchNeuro, and Thirdwayv

Date: March 2026